EURORDIS has played a crucial role in the development of ERNs through the EU directive on cross-border health care, and has established a European Patient Advocacy Group (ePAG) for each ERN disease grouping. EURORDIS has also implemented an ePAG leadership capacity-building programme, which empowers ePAG patient representatives with the knowledge and skills they need to be able to effectively participate in ERN activities. Therefore, EURORDIS membership is strongly advised for Endo-ERN ePAG representatives.
Subscribe to our email newsletter for useful information and valuable resources.